Samsung Group said Thursday it will invest in Arbor Biotechnologies, a US-based gene editing company, through its Life ...
Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons ...
The Chosun Ilbo on MSN
Samsung Invests in U.S. Gene-Editing Firm Arbor Biotechnologies
Samsung is proceeding with an investment in U.S.-based Arbor Biotechnologies (Arbor Bio), a company specializing in ...
News Medical on MSN
New Gene-Editing Tech Holds Promise for Treating Complex Genetic Diseases
Because the new method can replace a large stretch of defective DNA with a healthy sequence, the same retron-based package can fix any combination of mutations within that stretch of DNA without ...
Traditional breeding and genetic modification methods have struggled to keep pace with the rapid evolution of plant viruses. CRISPR/Cas systems, originally derived from bacterial immune responses, ...
Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room for improvement. A new paper by investigators from Mass General Brigham ...
Since 2019, MIT researchers have published a new concept called prime editing, which is more precise than regular CRISPR-Cas9 gene editing. As a result, it has fewer off-target effects and less chance ...
A Chinese scientist, He Jiankui, made a shocking announcement to the world in 2018: He had secretly engineered the birth of the first gene-edited babies. The birth of the twins was seen as reckless ...
Intellia Therapeutics said it is pausing two late-stage CRISPR gene-editing trials after a patient in one study was hospitalized with liver damage.
Intellia Therapeutics said on Wednesday that the U.S. Food and Drug Administration has placed a clinical hold on its two late ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results